TypeSafe AI
Developer infrastructure that turns unstructured inputs into typed decisions and probability scores for automated software workflows.
$870MSeries A
ParticipantD
DCVC
Activity from announced rounds
All recorded activity
DCVC is an investment firm identified by TypeSafe AI as an existing investor and by its own communications as a backer of Shennon Biotechnologies.
Recorded funding activity
TypeSafe turns unstructured inputs into typed decisions and probability scores for automated software. Shennon develops T-cell engager therapies for solid tumors. Separate TypeSafe financings remain separate events under one investor history.
Sources
- Rounds participated in
- 11
- Confirmed lead rounds
- 1 8 roles undisclosed
- New companies
- 10 First participation on record · 1 follow-on
- Funding in participating rounds
- $1.7B 10 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
11 in all activityTypeSafe AI
Developer infrastructure that turns unstructured inputs into typed decisions and probability scores for automated software workflows.
$40MSeed
LeadShennon Biotechnologies
Shennon Biotechnologies is developing precision T-cell engager immunotherapies for solid tumors.
$12MFunding
ParticipantCallosum
Software infrastructure allowing AI workloads to run across different chips and models
$100MSeed
Role not disclosedSabanto
Sabanto develops autonomous retrofit technology for agricultural equipment.
UndisclosedSeries B
Role not disclosedAtom Computing
Develops large-scale neutral-atom quantum computers for fault-tolerant commercial and government applications
$100MSeries C
Role not disclosedQuantum Motion
Builds utility-scale quantum computers using industry-standard silicon transistors
$160MSeries C
Role not disclosedKanvas Biosciences
Develops microbiome-based live biotherapeutics for cancer patients who do not respond to immunotherapy
$48MSeries A
Role not disclosedHalter
Develops GPS-enabled cattle collars using sensors, software and AI.
$220MSeries E
Role not disclosedChariot Defense
Chariot Defense develops power-distribution systems for military use.
$34MSeries A
Role not disclosedProxima
Develops AI-driven drug discovery for proximity therapeutics
$80MUndisclosed
Role not disclosed